News + Events

The Cluster brings together five pragmatic clinical trials on minimally invasive diagnostics: DEFINITIVE, MONALISA, RESOLVE, PREMIO COLLAB and ENDEAVOR. One of the cluster’s aims is to engage patients, caregivers and the general public to research and cluster’s activities. By actively engaging with the community, the Cluster wants to ensure that its work aligns with the needs and expectations of those it aims to benefit. In this regard, the Cluster has recorded a comprehensive video with public dissemination level, serving as an engaging summary, making the complex scientific endeavours of our Cluster accessible and understandable to a wide audience.

Click here and scroll down, to see the video.

The RESOLVE project will participate in the “5 Years EU Cancer Mission: Stronger Through Connection” event, taking place from 29 September to 1 October 2026 in Brussels, Belgium.

The event, organized by the European Commission, brings together researchers, clinicians, policymakers, patients, innovators, funders and industry representatives to celebrate five years of the EU Cancer Mission and explore the path towards its 2030 goals.

As part of the project showcases, RESOLVE will contribute to this European exchange, highlighting the project’s work and its contribution to strengthening collaboration and innovation in cancer research and care.

We look forward to connecting with fellow projects and stakeholders, sharing experiences, and helping shape the next chapter of the EU Cancer Mission.

Learn more about the EU Cancer Mission Showcase Event

The 2025 update of the ELN-DAVID MRD guideline harmonizes MRD assessment for each AML

Click here for the publication.

The new image video of the EU Diagnostics and Treatment cluster is available, please click here to access.

On April 10, 2024 the kick off meeting in the Congress Center Rosengarten, Mannheim – Germany marked the start of the RESOLVE project with all partners.

Next General Assembly will be on Feb. 26th, 2025 in Mannheim